Works by Kurkela, Mika
Results: 9
Efflux and uptake transport and gut microbial reactivation of raloxifene glucuronides.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2025, v. 136, n. 1, p. 1, doi. 10.1111/bcpt.14107
- By:
- Publication type:
- Article
Potent Inhibitors of the Human UDP-Glucuronosyltransferase 2B7 Derived from the Sesquiterpenoid Alcohol Longifolol.
- Published in:
- ChemMedChem, 2007, v. 2, n. 6, p. 881, doi. 10.1002/cmdc.200600246
- By:
- Publication type:
- Article
Fluorescence-Based High-Throughput Screening Assay for Drug Interactions with UGT1A6.
- Published in:
- Assay & Drug Development Technologies, 2011, v. 9, n. 5, p. 496, doi. 10.1089/adt.2010.0349
- By:
- Publication type:
- Article
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
- Published in:
- Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00579-8
- By:
- Publication type:
- Article
Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17.
- Published in:
- Biological Chemistry, 2006, v. 387, n. 4, p. 407, doi. 10.1515/BC.2006.055
- By:
- Publication type:
- Article
Introduction of an electrochemical point‐of‐care assay for quantitative determination of paracetamol in finger‐prick capillary whole blood samples.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 9, p. 2933, doi. 10.1111/bcp.15794
- By:
- Publication type:
- Article
Relationship of Edoxaban Plasma Concentration and Blood Coagulation in Healthy Volunteers Using Standard Laboratory Tests and Viscoelastic Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 4, p. 522, doi. 10.1002/jcph.1758
- By:
- Publication type:
- Article
Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2008, v. 21, n. 9, p. 537, doi. 10.1093/protein/gzn030
- By:
- Publication type:
- Article
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 71, doi. 10.1002/cpt.3067
- By:
- Publication type:
- Article